DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/bgxvrb/the_us_market_for) has announced the addition of the "The US Market for Rx to OTC Switches, 7th Edition" report to their offering.
This comprehensive report provides an in-depth analysis of the US Rx to OTC Switches market, including current and future drivers, challenges and opportunities. The report covers the key topics all market participants should be aware of, and provides the confidence needed to make informed business decisions within this market.
Segments profiled in the report include:
- Smoking Cessation
- Weight Loss
- Gastrointestinal Drugs
- Hair Loss Products
- Analgesics, NSAIDs, and Pain Treatments
- Oral Care
- Overactive Bladder
- Rectal Ointments
- Cough, Cold, and Sinus Products
In addition to the areas with switches in place, Kalorama Information has identified other areas which may be open to Rx-to-OTC switches in the future and are in development. These products are listed. Present revenues and past revenues for segment markets consist of the switched brands and OTC drugs containing switched ingredients. Five year forecasts are provided.
In addition to this information, the study tracks current issues and trends affecting the industry and identifies trends that may arise in the future. Each segment provides an overview, descriptions of products on the market, market estimates and forecasts, and competitive analysis of leading providers. The report includes statistical information for conditions and diseases affecting the U.S. population, including detail discussions, tables and figures.
THE OTC DRUG INDUSTRY
ALLERGY, COUGH, COLD, AND SINUS PRODUCTS
ANALGESICS AND OTHER PAIN RELIEVERS
SMOKING CESSATION PRODUCTS
OTHER DRUG CLASSIFICATIONS
TOTAL RX-TO-OTC DRUG MARKET SUMMARY
PROFILES FOR MAJOR RX-TO-OTC PARTICIPANTS
For more information visit http://www.researchandmarkets.com/research/bgxvrb/the_us_market_for